The activation of vagal afferent nerves by microorganisms has been demonstrated by injection of colonies of Lactobacillus johnsonii into the duodenum, thus resulting in improvement in gastric vagal activity [42]
References: Krinsky DL, LaValle JB, Hawkins EB, et al
Tirzepatide has no evidence of causing that
FDA-approved GLP-1s like Wegovy, Ozempic, Mounjaro, and Zepbound offer certainties that compounded versions simply cant, including: Consistent, tested ingredients in every dose Manufacturing facilities that meet strict quality standards Pre-filled pens that deliver precise amounts every time Comprehensive tracking of side effects Long-term studies on safety and effectiveness Regular inspections of manufacturing facilities Standardized patient information and warning labels With compounded versions, the risks are very real
Many insurance companies including Medicare (and Medicare Part D) cover Wegovy for the prevention of heart disease, heart attack, and stroke in patients with existing cardiovascular diseases and either obesity or overweight